IRD
Opus Genetics, Inc.Company with tickers: IRD
CIK
1228627
CUSIP
67577R102
Shares Outstanding
81,395,539
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $2,157,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $16,521,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | — | ||||
| Operating Income | $-14,364,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-65,535,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.75 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.75 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |